Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones

Accession ARO:3003929
CARD Short NameNgon_parC_FLO
DefinitionPoint mutations in Neisseria gonorrhoeae parC protein that confer resistance to fluoroquinolone by reducing affinity to antibiotic binding site.
AMR Gene Familyfluoroquinolone resistant parC
Drug Classfluoroquinolone antibiotic
Resistance Mechanismantibiotic target alteration
Resistomes with Sequence VariantsNeisseria gonorrhoeaeg+p+wgs, Neisseria meningitidiswgs
Classification11 ontology terms | Show
Parent Term(s)3 ontology terms | Show
+ confers_resistance_to_antibiotic ciprofloxacin [Antibiotic]
+ fluoroquinolone resistant parC [AMR Gene Family]
+ confers_resistance_to_antibiotic sitafloxacin [Antibiotic]
Publications

Kubanov A, et al. 2016. BMC Infect. Dis. 16:389 Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015). (PMID 27506605)

Kivata MW, et al. 2019. BMC Microbiol. 19(1):76 gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya. (PMID 30961546)

Ye M, et al. 2024. Antibiotics (Basel) 13(5): Emergence of Neisseria gonorrhoeae Clone with Reduced Susceptibility to Sitafloxacin in China: An In Vitro and Genomic Study. (PMID 38786196)

Resistomes

Prevalence of Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 413 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).

Prevalence: protein variant model (view sequences)

SpeciesNCBI ChromosomeNCBI PlasmidNCBI WGSNCBI GI
Neisseria gonorrhoeae33.75%0.51%37%0%
Neisseria meningitidis0%0%0.09%0%
Show Perfect Only


Detection Models

Model Type: protein variant model

Model Definition: Protein Variant Models (PVM) perform a similar search as Protein Homolog Models (PHM), i.e. detect protein sequences based on their similarity to a curated reference sequence, but secondarily screen query sequences for curated sets of mutations to differentiate them from antibiotic susceptible wild-type alleles. PVMs are designed to detect AMR acquired via mutation of house-keeping genes or antibiotic targets, e.g. a mutated gyrase resistant to aminocoumarin antibiotics. PVMs include a protein reference sequence (often from antibiotic susceptible wild-type alleles), a curated bit-score cut-off, and mapped resistance variants. Mapped resistance variants may include any or all of single point mutations, insertions, or deletions curated from the scientific literature. A Strict RGI match has a BLASTP bit-score above the curated BLASTP cutoff value and contains at least one curated mutation from amongst the mapped resistance variants, while a Loose RGI match has a bit-score less than the curated BLASTP bit-score cut-off but still contains at least one curated mutation from amongst the mapped resistance variants.

Bit-score Cut-off (blastP): 1400

Legend:

  • discovered in clinical, agricultural, or environmental isolates

  • discovered via laboratory selection experiments

  • ReSeqTB https://platform.reseqtb.org

Published Variants:


>gb|AAW89918.1|+|Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones [Neisseria gonorrhoeae FA 1090]
MNTQPHASHTDSNTLMLGRYAERAYLEYAMSVVKGRALPEVSDGQKPVQRRILFAMRDMG
LTAGAKPVKSARVVGEILGKYHPHGDSSAYEAMVRMAQDFTLRYPLIDGIGNFGSRDGDG
AAAMRYTEARLTPIAELLLSEINQGTVDFMPNYDGAFDEPLHLPARLPMVLLNGASGIAV
GMATEIPSHNLNEVTQAAIALLKKPTLETADLMQYIPAPDFAGGGQIITPADELRRIYET
GKGSVRVRARYEIEKLARGQWRVIVTELPPNANSAKILAEIEEQTNPKPKAGKKQLNQDR
LNTKKLMLDLIDRVRDESDGEHPVRLVFEPKSSRIDTDTFINTLMAQTSLEGNVSMNLVM
MGLDNRPAQKNLKTILQEWLDFRVVTVTRRLKFRLNQVEKRLHILEGRLKVFLHIDEVIK
VIRESDDPKADLMAVFGLTEIQAEDILEIRLRQLARLEGFKLEKELNELREEQGRLNIFL
GDENEKRKLIIKEMQADMKQFGDARRTLVEEAGRAVLTQTAADEPITLILSEKGWIRSRA
GHNLDLSQTAFKEGDRLKQTLEGRTVLPVVILDSSGRTYSIDAAEIPGGRGDGVPVSSLI
ELQNGAKPVAMLTGLPEQHYLLSSSGGYGFIAKLGDMVGRVKAGKVVMTADSGETVLPPV
AVYASSFINPDCKIIAATSQNRALAFPIGELKIMAKGKGLQIIGLNAGESMTHTAVSSEP
EILIESEGRRGAAHKDRLPVALIEAKRGKKGRLLPISGSLKQLSSPK



>gb|AE004969.1|+|1210524-1212827|Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones [Neisseria gonorrhoeae FA 1090]
ATGAATACGCAACCGCACGCTTCCCATACCGATTCCAACACGCTGATGCTCGGCCGATACGCCGAACGCGCCTATCTCGAATACGCCATG
AGCGTGGTCAAAGGCCGCGCGCTGCCTGAAGTTTCAGACGGCCAAAAGCCCGTGCAGCGGCGCATTTTGTTTGCCATGCGCGATATGGGT
TTGACGGCGGGGGCGAAGCCGGTGAAATCGGCGCGCGTGGTCGGCGAGATTTTGGGTAAATACCATCCGCACGGCGACAGTTCCGCCTAT
GAGGCGATGGTGCGCATGGCTCAGGATTTTACCTTGCGCTACCCCTTAATCGACGGCATCGGCAACTTCGGTTCGCGCGACGGCGACGGG
GCGGCGGCGATGCGTTACACCGAAGCGCGGCTGACGCCGATTGCGGAATTGCTGTTGTCCGAAATCAATCAGGGGACGGTGGATTTTATG
CCGAACTACGACGGCGCGTTTGACGAGCCGCTGCACCTTCCCGCCCGCTTGCCTATGGTGTTGCTCAACGGCGCGTCGGGCATCGCGGTG
GGTATGGCGACCGAGATTCCGTCGCACAATTTGAACGAAGTCACGCAGGCGGCGATTGCACTGTTGAAGAAACCGACGCTGGAAACCGCC
GACCTGATGCAATATATTCCTGCTCCCGATTTTGCCGGCGGCGGTCAAATCATCACGCCGGCGGACGAATTGCGCCGTATTTACGAAACC
GGCAAGGGCAGCGTGCGCGTGCGTGCGCGTTATGAAATCGAGAAATTGGCGCGCGGACAGTGGCGCGTCATCGTAACCGAACTGCCGCCG
AACGCCAACTCCGCCAAAATCCTTGCCGAAATCGAAGAGCAAACCAACCCGAAACCGAAAGCGGGTAAAAAGCAGCTCAACCAAGACCGG
CTCAATACCAAAAAGCTGATGCTGGATTTAATCGACCGCGTGCGCGACGAGTCCGACGGCGAACATCCCGTGCGCCTTGTATTTGAACCG
AAATCCAGCCGCATCGATACCGATACCTTCATCAACACGCTGATGGCGCAAACTTCGCTGGAAGGCAATGTGTCCATGAACTTGGTGATG
ATGGGTTTGGACAACCGCCCCGCGCAGAAAAACCTGAAAACGATTTTGCAGGAATGGCTGGATTTCCGCGTCGTTACCGTAACACGCCGT
CTGAAATTCCGTTTAAACCAAGTGGAAAAACGGCTGCACATCCTCGAAGGCCGTCTGAAAGTCTTTCTGCACATCGACGAAGTGATTAAA
GTCATCCGCGAATCGGACGACCCGAAAGCCGATTTGATGGCGGTGTTCGGGCTGACCGAAATCCAAGCCGAAGACATTTTGGAAATCCGC
CTGCGTCAGCTGGCGCGTTTGGAAGGTTTCAAACTCGAAAAAGAATTGAACGAATTGCGCGAAGAACAAGGCCGTCTGAATATCTTTTTG
GGCGACGAAAACGAAAAACGCAAGCTGATTATCAAAGAGATGCAGGCGGACATGAAGCAGTTCGGCGACGCGCGCCGCACGCTGGTGGAA
GAGGCCGGACGCGCCGTGCTGACACAAACCGCCGCCGACGAACCCATCACGCTGATTTTGTCGGAAAAAGGCTGGATACGCAGCCGTGCC
GGACATAATCTCGATTTGAGCCAAACCGCGTTCAAAGAAGGCGACCGCCTCAAACAAACCCTTGAAGGCCGCACTGTTTTACCCGTCGTC
ATCCTCGATTCATCGGGCAGAACCTACTCGATCGATGCCGCCGAAATCCCCGGCGGACGCGGCGACGGCGTACCGGTTTCCTCCTTAATC
GAGTTGCAAAACGGCGCGAAACCCGTCGCGATGTTGACAGGATTGCCGGAACAACATTATTTATTATCAAGCAGCGGCGGCTACGGCTTT
ATCGCCAAGCTGGGCGATATGGTCGGACGCGTGAAAGCGGGCAAAGTGGTGATGACCGCAGACAGCGGCGAAACCGTCCTGCCGCCGGTT
GCCGTCTATGCCTCCTCGTTCATCAACCCCGACTGCAAAATCATTGCAGCCACCAGTCAAAACCGCGCCCTCGCCTTCCCCATCGGCGAA
TTGAAAATTATGGCGAAAGGCAAAGGACTGCAAATCATCGGATTAAACGCCGGCGAATCGATGACGCATACCGCCGTTTCTTCCGAGCCG
GAAATCCTGATTGAAAGCGAAGGCAGGCGCGGCGCGGCGCACAAAGACCGCCTCCCCGTCGCCCTGATTGAGGCAAAACGCGGCAAAAAA
GGCAGACTGTTGCCCATATCGGGCAGCCTGAAACAGCTTTCTTCCCCCAAATAA